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Background: Following claims that some plants have antimicrobial activities against infectious microbes, the
in vitro antimicrobial activities of different solvent fractions of ethanolic extract of Cryptolepis sanguinolenta were
evaluated against eight standard bacteria and clinical isolates.
Methods: The solvent partitioning protocol involving ethanol, petroleum ether, chloroform, ethyl acetate and
water, was used to extract various fractions of dried pulverized Cryptolepis sanguinolenta roots. Qualitative
phyto-constituents screening was performed on the ethanol extract, chloroform fraction and the water fraction. The
Kirby Bauer disk diffusion method was employed to ascertain the antibiogram of the test organisms while the agar
diffusion method was used to investigate the antimicrobial properties of the crude plant extracts. The microplate
dilution method aided in finding the MICs while the MBCs were obtained by the method of Nester and friends. The
SPSS 16.0 version was used to analyze the percentages of inhibitions and bactericidal activities.
Results: The phytochemical screening revealed the presence of alkaloids, reducing sugars, polyuronides,
anthocyanosides and triterpenes. The ethanol extract inhibited 5 out of 8 (62.5%) of the standard organisms and 6
out of 8 (75%) clinical isolates. The petroleum ether fraction inhibited 4 out of 8 (50%) of the standard microbes
and 1 out of 8 (12.5%) clinical isolates. It was also observed that the chloroform fraction inhibited the growth of all
the organisms (100%). Average inhibition zones of 14.0 ± 1.0 mm to 24.67 ± 0.58 mm was seen in the ethyl acetate
fraction which halted the growth of 3 (37.5%) of the standard organisms. Inhibition of 7 (87.5%) of standard strains
and 6 (75%) of clinical isolates were observed in the water fraction. The chloroform fraction exhibited bactericidal
activity against all the test organisms while the remaining fractions showed varying degrees of bacteriostatic
activity.
Conclusion: The study confirmed that fractions of Cryptolepis sanguinolenta have antimicrobial activity. The
chloroform fraction had the highest activity, followed by water, ethanol, petroleum ether and ethyl acetate
respectively. Only the chloroform fraction exhibited bactericidal activity and further investigations are needed to
ascertain its safety and prospects of drug development.Introduction
Cryptolepis sanguinolenta (Lindl.) Schltr. (Periplocaceae)
is a plant mostly found in the tropical rain forest regions
of Africa with several species. C sanguinolenta is the
most common in Ghana. This species is found on moun-
tainous territories in Ghana, especially the Akwapim
and Kwahu mountains [1,2]. Paulo and Houghton [3],
described the plant as a slender thin stemmed climbing
shrub with orange-coloured juice in the cut stem and* Correspondence: scktaysammy9@yahoo.com
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distribution, and reproduction in any mediumlike most medicinal herbs or plants, the exact history on
the usage of the plant is not well established, but it is
confirmed that some indigenous inhabitants in the
Akwapim and Kwahu mountainous areas in Ghana use
the plant to manage various forms of fever, malaria and
some infections caused by bacteria [4]. It has also been
established that, the extract of C. sanguinolenta has anti-
muscarinic, vasodilating, noradrenergic, antithrombotic,
anti-inflammatory, and hypoglycemic activities [5]. The
part of the plant mostly used is the root and the extract
is obtained in the aqueous form by boiling, or by alcohol
extraction, popularly referred to as “bitters” in Ghana.
Thus, C. sanguinolenta is a potential medicinal plant thatCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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Previous in vitro studies have compared the effect of
ethanol, cold and hot aqueous extracts of C. sanguinolenta
as antimicrobial agents using Gram positive and Gram
negative organisms as well as C. albicans. Eighty five
percent of the test microbes were inhibited by the ethanol
extract while the cold and hot aqueous extracts inhibited
seventy five percent of the test microbes respectively [6].
The current study investigated the antimicrobial activity of
various solvent fractions of ethanolic extract of C. sanguino-
lenta, with the aim of identifying the bioactive fractions of
the extract as well as finding out the degree of activity
against selected pathogenic bacteria.
Methodology
Ethical issues
The study protocol was approved by the Committee on
Human Research Publication and Ethics of the School of
Medical Sciences, Kwame Nkrumah University of Science
and Technology (CHRPE/187/10). Informed consent was
obtained from participants.
Experimental materials
Voucher specimens (Voucher # CSRPM 1911), of the
roots of C. sanguinolenta were harvested, dried and
stored in the herbarium of the institute until needed.
Test organisms used
The test organisms used in this study were obtained
from the Komfo Anokye Teaching Hospital (KATH),
Kumasi, Ghana. These organisms were confirmed at the
CSRPM using biochemical and Analytical Profile Index
(API) kits. The isolates used consisted of one strain each
of Staphylococcus aureus, Staphylococcus saprophyticus,
Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis,
Pseudomonas aeruginosa, Salmonella typhi and Salmonella
typhimurium. The following standard strains of bacteria
were used; S. aureus ATCC 25923, S. saprophyticus
ATCC 15305, E. coli ATCC 25922, K. pneumoniae ATCC
33495, Proteus mirabilis ATCC 49565, P. aeruginosa
ATCC 27853, S. typhi ATCC 19430 and S. typhimurium
ATCC 14028.
Antibiotic susceptibility testing
All the isolates were subjected to antimicrobial suscepti-
bility test using Kirby-Bauer disc diffusion method as
described by NCCLS [7]. Briefly peptone water subcul-
tures which had attained the 0.5 McFarland turbidity
standards were used to seed the surface of the Muellar-
Hinton agar plates. Antibiotics disks [Amikacin (30 μg/
disc), Ampicillin (10 μg/disc), Penicillin (10 μg/disc), Clox-
acillin (5 μg/disc), Erythromycin (15 μg/disc), Tetracycline
(30 μg/disc), Gentamicin (10 μg/disc), Cotrimoxazole
(25 μg/disc), Chloramphenicol (30 μg/disc), and Cefixime(30 μg/disc), Cefuroxime (30 μg/disc), and Cefotaxime
(30 μg/disc)] were carefully placed on the surface of the
plates and incubated at 37°C for 16–18 hours.
Ethanolic extract C. Sanguinolenta
One kilogram (1 kg) of dried pulverized C. sanguinolenta
roots was macerated in 8 L of 70% ethanol in water and
stored at room temperature for 48 hours. The resultant
extract was filtered, concentrated and subsequently
freeze-dried. The freeze-dried sample was kept in the
refrigerator at 4°C until needed. About 6 grams of the
freeze-dried sample was reserved whilst the remaining
was subjected to the solvent partitioning protocol as
previously described [8,9].
Phytochemical screening of the extracts
The phytochemical constituents of the ethanol extracts,
chloroform fraction and the water fraction were deter-
mined. The phytochemical parameters assayed for, included
saponins, reducing sugars, polyuronides, cyanogenic glyco-
side, alkaloid, triterpenes, phytosterols, flavonoids, antho-
cyanosides and phenolics [10].
Antimicrobial activity of the fractions/compounds
The agar diffusion method was used to investigate the
antibacterial properties of both the crude ethanolic
extracts and sequential solvent fractions of C. sanguino-
lenta, as described in the National Committee for Clinical
Laboratory Standards [11] and the National Center for
Infectious Disease, Center for Disease Control and
Prevention [12].
Determination of the minimum inhibitory concentration
(MIC)
The MIC values of the crude extract were determined
using the microplate dilution method as described by
Eloff [13]. Briefly, 100 μl of 32 mg/ml of the ethanolic
extract was added to 100 μl of sterile bacteriological
peptone in the first well in the 96-well microplate and
mixed well with a micropipette, 100 μl of this dilution
was transferred to the bacteriological peptone in subse-
quent wells yielding two-fold serial dilution in the ori-
ginal extract. The process was repeated for the other
plant extracts in other columns of the microplate. A
reference solution of chloramphenicol was also serially
diluted in another column of the microplate as a positive
control. 100 μl of actively growing test organisms (0.5
McFarland standards) was added to each of the wells ex-
cept the negative control. Triplicate of each microplate
was made and the procedure repeated for the other
organisms. The microplates were incubated at 37°C for
24 hours. After the incubation, 40 μl of 0.2 mg/ml INT
was added to each of the wells. The microplates were
then examined after additional 60 minutes incubation.
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of the INT to formazan), and the lowest concentration
at which the red colour is apparently invisible compared
to the next dilution was taken as the MIC value.
Determination of the minimum bactericidal concentration
(MBC)
The MBC values were deduced from those wells with
the lowest concentrations at which no growth (colour
development) was observed after culturing for 24 hours
of incubation as described by Nester et al., [14].
Results
Phytochemical screening
Phytochemical screening performed on the ethanol extract
as well as the water and chloroform fractions revealed the
presence of reducing sugars, polyuronides, alkaloids and
anthocyanosides. The water fraction in addition contains
triterpenes (Table 1).
Antibiotic susceptibility tests
The antibiotic susceptibility test performed on all the 16
pathogenic bacteria revealed a high resistance pattern to
all the first line antibiotics used in the study. It was
observed that, all the microbes were resistant to AMP,
CXC, TET and PEN, while the remaining antibiotics
exhibited varying degrees of resistance and susceptibility
(Figure 1).
Susceptibility of the microbes to various fractions of C.
Sanguinolenta
As depicted in Table 2, 11 out of the 16 (68.75%)
microbes used were inhibited by the ethanol extract with
average zones of inhibition ranging from 9.33± 0.58 to
35.67 ± 0.58 mm. Another 11 out of 16 isolates were not
susceptible to the petroleum ether fraction; however, both






Saponins - - -
Reducing sugars + + +
Polyuronides + + +
Cyanogenic glycosides - - -
Alkaloids + + +
Triterpenes - + -
Phytosterols - - -
Flavonoides - - -
Anthocyanosides + + +
+=present, - = absent.susceptible with 27.00 ± 1.00 mm and 14.67± 0.58 mm as
the average zones of inhibition respectively. The chloro-
form fraction registered 100% inhibitory activity against
all the sixteen isolates with inhibition zones averagely
ranging between 9.33 ± 0.58 and 32.33± 0.58 mm. The
ethyl acetate fraction inhibited the growth of 3 out of the
16 (18.75%) isolates used with average zones of inhibition
ranging from 14.00 ± 1.00 to 24.67 ± 0.58 mm. The water
fraction of C. sanguinolenta inhibited 12 out of the 16
(75.00%) microbes used with average zone diameters
ranging from 8.67 ± 0.58 to 38.33 ± 0.58 mm (Table 2).
Chloramphenicol inhibited the growth of Proteus mirabilis
(ATCC 49565), E. coli (ATCC 25922), S. aureus (ATCC
25923) and S. saprophyticus (ATCC 15305) representing
25.00% of the total number of microbes used.
MICs and MBCs of the ethanol extract of C. Sanguinolenta
and its partitioned fractions
The MICs and MBCs of the partitioned fractions of C.
sanguinolenta showed varying degrees of potency. These
tests were performed only on the test organisms that
showed inhibition during the antimicrobial screening.
With the exception of the chloroform fraction which
showed consistent bactericidal results in both MICs and
MBCs to all the test organisms, the remaining fractions
were bacteriostatic to the microbes. The ethanol extract
had MIC values ranging from 8.0 to 32.0 mg/ml for the
wild strains while that of the standard strains ranged
from 4.0 to 32.0 mg/ml. The chloroform extract had
MIC values ranging from 1.0 to 2.0 mg/ml for the stand-
ard strains and 0.5 to 2.0 mg/ml for the wild strains with
MBC values from 2.0 to 32.0 mg/ml. The petroleum
ether fraction exhibited MIC values ranging from 16.0 to
32.0 mg/ml among P. mirabilis, S. saprophyticus ATCC
15305, S. aureus ATCC25923, P. mirabilis ATCC 49565
and E. coli ATCC 25922, while MIC value of 32.0 mg/ml
was observed among S. saprophyticus ATCC 15305, S.
aureus ATCC25923 and P. mirabilis ATCC 49565 in the
ethyl acetate fraction. The water fraction exhibited MIC
values ranging from 8.0 mg/ml to 32.0 mg/ml in twelve
of the microbes used (Table 3).
Discussion
The emergence of antibiotic resistance has prompted
scientist to assiduously research into medicinal plants,
not only to ascertain claims of efficacy and safety but
also to discover alternative candidates for drug develop-
ment. In the same regard the current study sought to
elucidate the antimicrobial activity of ethanolic fractions
of Cryptolepis sanguinolenta.
Several studies from the West African sub-region have
reported the potency of C. sanguinolenta against clinical
malaria [4,15]. The efficacy of its different alkaloids hydro-



























Figure 1 Anti biotic resistance patterns of microorganisms used.
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terial has also been reported [16,17].
High resistance observed in the clinical isolates is con-
sistent with emerging antimicrobial resistance worldwide,
especially in developing nations like Ghana [18,19]. All
bacteria tested were completely resistant to the relatively
affordable antibiotics available today; like ampicillin, cloxa-
cillin, tetracycline and penicillin, while observed resistance
to gentamicin was below fifty percent. High anti-bacterial
resistance to ampicillin, chloramphenicol, streptomycin,
sulphonamides and tetracycline in animals and humans





Salmonella typhi ATCC 19430 18.00 ± 0.00 0.00 ± 0.00
Salmonella typhi 0.00 ± 0.00 0.00 ± 0.00
Salmonella typhimurium ATCC 14028 0.00 ± 0.00 0.00 ± 0.00
Salmonella typhimurium 0.00 ± 0.00 0.00 ± 0.00
Proteus mirabilis ATCC 49565 9.33 ± 0.58 27.00 ± 1.00
Proteus mirabilis 20.67 ± 0.58 14.67 ± 0.58
Pseudomonas aeruginosa ATCC 27853 0.00 ± 0.00 0.00 ± 0.00
Pseudomonas aeruginosa 20.00± 0.00 ± 0.00
Klebsiella pneumoniae ATCC 33495 0.00 ± 0.00 0.00 ± 0.00
Klebsiella pneumonia 22.33 ± 0.58 0.00 ± 0.00
Escherichia coli ATCC 25922 19.67 ± 0.58 19.670.58
Escherichia coli 9.67 ± 0.58 0.00 ± 0.00
Staphylococcus aureus ATCC 25923 35.67 ± 0.58 32.670.58
Staphylococcus aureus 18.67 ± 0.58 0.00 ± 0.00
Staphylococcus saprophyticus ATCC 15305 20.33 ± 0.58 24.33 ± 1.15
Staphylococcus saprophyticus 10.00 ± 0.00 0.00 ± 0.00simultaneous use of antimicrobial agents in both human
and veterinary medicines have widened the spectrum of
resistance to cover trimethoprim, fluoroquinolones and
third-generation cephalosporin [21]. Even though there are
natural ways microbes develop resistance [22], compliance
with pharmaco-vigilance policies will help slow the rate of
antibiotic resistance.
The phytochemical analyses revealed the presence of
alkaloids, polyuronides and anthocyanosides in the etha-
nol extract, chloroform and water fractions. However,
triterpenes were found only in the water fraction. There








19.67 ± 0.58 0.00 ± 0.00 16.67 ± 1.15 0.00 ± 0.00
11.33 ± 0.58 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
11.33 ± 0.58 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
9.33 ± 0.58 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
20.67 ± 0.58 14.00 ± 1.00 10.33 ± 0.58 14.67 ± 0.58
19.33 ± 0.58 0.00 ± 0.00 18.67 ± 0.58 0.00 ± 0.00
11.00 ± 1.00 0.00 ± 0.00 9.67 ± 0.58 0.00 ± 0.00
15.67 ± 0.58 0.00 ± 0.00 24.33 ± 1.15 0.00 ± 0.00
10.67 ± 0.58 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
15.67 ± 0.58 0.00 ± 0.00 23.67 ± 0.58 0.00 ± 0.00
14.67 ± 0.58 0.00 ± 0.00 21.33 ± 1.15 14.33 ± 0.58
11.33 ± 0.58 0.00 ± 0.00 8.67 ± 0.58 0.00 ± 0.00
32.33 ± 0.58 24.67 ± 0.58 38.33 ± 0.58 26.00 ± 1.00
14.33 ± 0.58 0.00 ± 0.00 17.00 ± 2.00 0.00 ± 0.00
19.67 ± 0.58 17.33 ± 0.58 21.00 ± 1.00 19.33 ± 0.58
10.67 ± 0.58 0.00 ± 0.00 9.33 ± 0.58 0.00 ± 0.00
Table 3 The MIC and MBC of the extract and fractions of C. sanguinolenta
Test organisms Ethanolic extract Petroleum ether
extract
Chloroform extract Ethyl acetate extract Water extract
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
Salmonella typhi 32.0 BST X X 1.0 4.0 X X 8.0 BST
ATCC 19430
Salmonella typhimurium ATCC 14028 X X X X 2.0 4.0 X X X X
Proteus mirabilis ATCC 49565 32.0 BST 32.0 BST 2.0 2.0 32.0 BST 16.0 BST
Pseudomonas aeruginosa ATCC 27853 X X X X 2.0 4.0 X X 16.0 BST
Klebsiella pneumoniae ATCC 33495 X X X X 4.0 8.0 X X X X
Escherichia coli 16.0 BST 16.0 BST 4.0 16.0 X X 8.0 BST
ATCC 25922
Staphylococcus aureus 4.0 BST 32.0 BST 2.0 4.0 32.0 BST 16.0 BST
ATCC 25923
Staphylococcus saprophyticus ATCC 15305 4.0 BST 16.0 X 2.0 4.0 32.0 BST 32.0 BST
Clinical Isolates
Salmonella typhi X X X X 1.0 8.0 X X X X
Salmonella typhimurium X X X X 2.0 16.0 X X X X
Proteus mirabilis 8.0 BST 32.0 BST 1.0 8.0 X X 32.0 BST
Pseudomonas aeruginosa 32.0 BST X X 1.0 8.0 X X 32.0 BST
Klebsiella pneumoniae 32.0 BST X X 2.0 32.0 X X 32.0 BST
Escherichia coli 32.0 BST X X 1.0 32.0 X X 32.0 BST
Staphylococcus aureus 32.0 BST X X 0.5 4.0 X X 16.0 BST
Staphylococcus saprophyticus 32.0 BST X X 1.0 4.0 X X 16.0 BST
X=no test done, BST = Bacteriostatic.
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et al., [18], ethanol-water extract isolation of the alka-
loids quindoline, hydroxycryptolepine, cryptolepine-HCl,
and the corresponding base cryptolepine was found to
inhibit Gram-positive bacteria and some selected Gram-
negative bacteria [18]. Terpenoids are known to have
antimicrobial properties [23]. For instance, triterpenes,
terpenoids or isoprenoids, are reported to show high
antifungal or antimicrobial properties with possible
effect on the non-mevalonate pathway. This pathway is
essential in fungi, protozoans, gram-negative bacteria
and other micro-organisms for the synthesis of cell
membrane components, prenylation of proteins and as a
secondary source of carbon [24]. Reducing sugars have
been reported to have antibacterial property [25,26]. The
petroleum ether acting as a defatting agent removed oils
from the extract. This may be a contributing factor to
the microbial susceptibility observed since most oils
from plants have antimicrobial activity [27]. The activity
of these phytochemical-constituents may be responsible
for the antimicrobial activities observed in the study.
The ethanol extract inhibited both Gram positive and
Gram negative bacteria with greater inhibition zones
observed among the Gram-positive microbes, probablydue to difference in cell wall structure and component.
This result is consistent with the work of Mills-
Robertson et al., [6]. The inhibition of S. saprophyticus,
E. coli and P. mirabilis confirm the use of the plant in
the treatment of UTI [28]. Aqueous and 80% Ethanol-
water extract from the root-bark of Cryptolepis sangui-
nolenta are known to have potent antibacterial, anti-
complementary, and moderate antiviral activities, but
not antifungal [18]. The petroleum ether fraction of the
ethanol extract of C. sanguinolenta inhibited the growth
of only the standard Gram-positive bacteria; however,
both the standard and wild strains of Proteus mirabilis
were susceptible. C. sanguinolenta has been shown to
contain alkaloids which function to cause cell lysis and
morphological changes in S. aureus [29]. The inhibition
of only the Gram-positive organisms as well as Proteus
mirabilis by the petroleum ether fraction may suggest
the presence of such compounds; hence the fraction
may be used as narrow spectrum antimicrobial.
The chloroform fraction registered hundred percent in-
hibitory activities against all the sixteen isolates. Paulo et
al., [17] investigated the antimicrobial activity of ethanol
extract and five alkaloids of C. sanguinolenta and observed
that P. aeruginosa was resistant to all the alkaloids and the
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chloroform fraction of C. sanguinolenta has inhibitory
activity against P. aeruginosa; hence, the fraction may be
used in the treatment of infections involving these MDR
organisms. The chloroform extracts of Thaumatococcus
danielli leaves have no significant antimicrobial activity
against Salmonella typhimurium, Shigella sp, Escherichia
coli and Staphylococcus aureus [30]. Moreover chloro-
form extracts of Centrosema pubescens inhibited the
growth of same organisms [31], a justification that the
inhibition was not caused by chloroform but rather its
constituents. It is thought that chloroform has the po-
tential of extracting some potent compounds which are
present in minute proportion in the ethanolic extract.
In addition, synergism may be a plausible explanation
for this observation [32–34]. These phenomena requires
further investigated.
The ethyl acetate fraction inhibited the growth of three
out of the sixteen (18.75%). All the other test microbes
(n=13) were not susceptible to the extract. The few organ-
isms inhibited by the fraction could be justified by the
dose-dependent activity observed by Cimanga et al., [18].
Probably the active compounds contained in the fraction
were not sufficient to inhibit most of the organisms. The
water fraction of C. sanguinolenta inhibited twelve out of
the sixteen (75.00%) microbes used. The growths of all the
Gram-positive microbes were inhibited. Non susceptibility
was observed among S. typhi, S. typhimurium, S. typhimur-
ium (ATCC 14028) and K. pneumoniae (ATCC 33495).
The remaining eight Gram-negative organisms were inhib-
ited by the extract. The aqueous fraction has been reported
to have a broad spectrum antimicrobial activity [6].
Gram-positive test organisms were generally susceptible
to the various fractions used. This may be due to the about
90% peptidoglycan component of the cell wall of Gram-
positive bacteria, which is not a regulatory in comparison
to the cell membrane of the gram negative bacteria, and
therefore, incapable of performing the function of selective
permeability, and thus allow substances to sieve through it.
The Gram-negative organisms showed varying resistance
to all fractions and extract except the chloroform fraction.
The Gram-negative bacteria cell wall consist of a peri-
plasmic space that contains many hydrolytic enzymes,
including β-lactamase, which destroy potentially dangerous
foreign substances present in this space.
All the extract and fractions showed MIC values ran-
ging from 0.5 mg/ml to 32 mg/ml but not all were bac-
tericidal. Considering the fact that the chloroform
fraction used is a crude extract, the MIC value recorded
(0.5 mg/ml) against S. aureus and a maximum of 4 mg/
ml in the other test organisms shows how potent it
could be used as an antimicrobial agent. MICs observed
in this study are high compared to some studies like
Akiyemi et al. [35]. They reported the effectiveness ofcrude extracts of three medicinal plants from Nigeria
against MRSA, and observed MICs ranging from 18.2
to 71.0 ug/ml. Another study [36] determined the anti-
microbial activity of three selected plants against Extended
Spectrum Beta Lactamase (ESBL)—producing Escherichia
coli and Klebsiella pneumoniae and found majority of the
microorganisms inhibited by 40 and 80μg/μl of the crude
extracts. However the current MICs observed is con-
sistently justified by similar studies. Navarro et al. [37]
investigating 12 methanolic plant extracts normally
used in traditional medicine in Mexico to cure infec-
tious diseases, examined the potential antimicrobial ac-
tivity against Staphylococcus aureus, Escherichia coli,
Pseudomonas aeruginosa and Candida albicans. They
reported significant antimicrobial effects, as MICs, ran-
ging between 0.6 and 40 mg/ml of crude extract against
the microbes. Another study also reported that Gram-
negative bacteria are hardly susceptible to the plant
extracts in doses less than 2 × 105 μg/mL [38].
Conclusion
In conclusion, the study confirmed that fractions of
Cryptolepis sanguinolenta have significant antibacterial
activity. Different fractions have varying antibacterial
activity against different organisms. The chloroform
fraction had the highest activity, followed by water, etha-
nol, petroleum ether and ethyl acetate respectively. It is
recommended that more research be conducted into the
individual compounds in the extracts; there is promise
in such to find very low MICs.
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